Written question asked by Stephen O'Brien (Conservative) on Tuesday, 22 July 2008, in the House of Commons. It was due for an answer on Monday, 6 October 2008. It was answered by Baroness Primarolo (Labour) on Monday, 6 October 2008 on behalf of the Department of Health.
Hepatitis
- Question
- To ask the Secretary of State for Health what (a) technology appraisals, (b) interventional guidelines, (c) clinical guidelines and (d) public health guidelines which have an effect on hepatitis B services are issued by the National Institute for Health and Clinical Excellence (NICE); what effect each has on hepatitis B; on what date each was issued; which workstreams under consideration by NICE have an effect on hepatitis B services; and if he will make a statement.
- Answer
-
The following technology appraisals have been issued by National Institute for Health and Clinical Service (NICE):"““Adefovir dipivoxil and pegylated interferon alpha-2a for the treatment of chronic hepatitis B”” (22 February 2006).""““Entecavir for the treatment of hepatitis B”” (27 August 2008)""““Telbivudine for the treatment of chronic hepatitis B”” (27 August 2008)"Copies of the technology appraisals have been placed in the Library and are available on NICE's website at:"www.nice.org.uk/Guidance/TA96/QuickRefGuide/pdf/English,""www.nice.org.uk/Guidance/TA153/Guidance/pdf/English and""www.nice.org.uk/Guidance/TA154/QuickRefGuide/pdf/English."A technology appraisal on tenofovir disoproxii fumarate for the treatment of hepatitis B will be published in May 2009. It was formally referred to NICE's workstream to appraise its clinical and cost effectiveness.There are no published clinical guidelines or guidelines in development that directly addresses the management of hepatitis B services. However, ““Drug Misuse, psychological interventions”” (July 2007) addresses the need for those who misuse drugs to reduce their exposure to blood-borne viruses where hepatitis B testing is recommended. A copy of this guidance has been placed in the Library and is available on NICE's website at:"www.nice.org.uk/nicemedia/pdf/CG051NICEguideline2.pdf"NICE is currently preparing the following public health guidelines, which are relevant to hepatitis B services:"““Needle and syringe programmes: providing injecting equipment to people who will inject drugs”” (to be published in February 2009)""““Guidance on differences in the uptake of immunisations (including targeted vaccines) in people younger than 19”” (to be published in June 2009)"There are no relevant interventional guidelines, which will have an effect on hepatitis B services.These technology appraisal and guidelines for those involved in the management of hepatitis B services will promote good practice in the treatment and prevention of hepatitis B infection.
Secondary information
- Type
- Written question
- Reference
- 222423; 480 c424W
- Session
- 2007-08
- Related items
- Subjects
- Hepatitis
- Link
- View this Written question on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2013-11-26 03:06:32 +0000
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1347993
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1347993
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1347993